IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,855 | -83.7% | 810 | -80.6% | 0.00% | -100.0% |
| Q2 2023 | $78,670 | +2428.8% | 4,169 | +414.7% | 0.00% | – |
| Q1 2023 | $3,111 | -22.6% | 810 | 0.0% | 0.00% | – |
| Q4 2022 | $4,018 | +0.4% | 810 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 810 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | 0.0% | 810 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 810 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | +20.0% | 810 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 810 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -28.6% | 810 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | +40.0% | 810 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +66.7% | 810 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 810 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 810 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 810 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 810 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 810 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -50.0% | 810 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $4,000 | – | 810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,477,879 | $37,720,000 | 0.69% |
| QVT Financial LP | 1,375,900 | $4,953,000 | 0.60% |
| RA Capital Management | 7,040,485 | $25,346,000 | 0.46% |
| Birchview Capital, LP | 380,000 | $1,368,000 | 0.46% |
| XTX MARKETS LLC | 18,861 | $68,000 | 0.33% |
| Fernwood Investment Management, LLC | 154,340 | $556,000 | 0.26% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $375,000 | 0.14% |
| Virtus ETF Advisers LLC | 70,213 | $253,000 | 0.13% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,251,458 | $4,505,000 | 0.13% |
| Assenagon Asset Management S.A. | 4,987,334 | $17,954,000 | 0.10% |